Insights
Dr. David Erritzoe to provide guidance on psychopharmacological research Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company
Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is
Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, today
Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“) is pleased to announce that the Company completed its acquisition of Lobo
Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company“), a biotechnology company focused on developing psychedelic medicines to treat addiction, is
New Placer Dome Gold Corp. (” New Placer Dome ” or the ” Company “) (TSX-V: NGLD) (OTCQB: NPDCF) (FSE: BM5) is pleased to announce plans for the 2021
Ares Strategic Mining Inc. (“ Ares ” or the “ Company ”) (TSXV:ARS) (OTC:ARSMF) (FRA:N8I1) is pleased to announce that, further to its news releases dated February 26, 2021,
Rritual Superfoods Inc. (” Rritual ” or the “Company” ) (CSE: RSF) (FSE: 0RW) (OTCQB: RRSFF) is pleased to provide the following letter to shareholders, outlining the Company’s advancements and increased retail
Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE: RSF) (FSE: 0RW) (OTC: RRSFF) is pleased to announce that the Company’s Product Innovation and Research team has completed testing on
Rritual Superfoods Inc. (“Rritual” or the “Company”) (CSE: RSF) (FSE: 0RW) (OTCQB: RRSFF) is pleased to announce that the Company has appointed Tinuiti as its Digital Advertising Agency.
Rritual Superfoods Inc. (” Rritual ” or the “Company” ) (CSE: RSF) (FSE: 0RW) (OTCQB: RRSFF) is pleased to announce its successful uplisting from the OTC Pink Sheets to the OTCQB®
Ares Strategic Mining Inc. (“Ares” or the “Company”) (TSXV:ARS) (OTC:ARSMF) (FRA:N8I1), is pleased to announce that it has received conditional approval to list its voting
Exclusive Content
Why Adrian Day remains bullish on gold following the Trump bump in equities…
Canada’s economy is largely underutilized, relying too heavily on natural resources…
Find out why falling birthrates, rising inflation, and soaring gold prices are connected…
For well over a century, gold stocks have been one of the most popular investment assets
among speculators. An essential fact sometimes ignored is that gold equities often drastically…
Authors for PinnacleDigest.com are not registered broker-dealers or financial advisors. Before investing in any securities, you should consult with your financial advisor and a registered broker-dealer. Never make an investment based solely on what you read on PinnacleDigest.com. As with all investments, an investor should carefully consider his investment objectives and risk tolerance before investing. Use of this Site constitutes acceptance of our Terms of Use, Privacy Policy and Disclosure & Compensation. The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of Pinnacle Digest.
Securities covered in articles on this website are highly speculative. When investing in speculative stocks of this nature, it is possible to lose your entire investment over time or even quickly. These are not suitable investments for most investors.
All statements in articles on this website are to be checked and verified by the reader. Articles on this website may contain technical or other inaccuracies, omissions, or typographical errors for which PinnacleDigest.com assumes no responsibility.
Please be aware and note the date in which articles are published on this website. As a result of the passing of time, the relevancy of the opinions and facts in articles are likely to diminish over time and may change without an update to the articles. As such, you cannot rely on the accuracy and timeliness of the information provided and should consider many of the articles irrelevant after an extended period of time from the date which it was published. Since there is no specific guideline as to how long an article may remain relevant, you should consider that all articles may be irrelevant shortly after they are published. This is especially true for articles that include information on publicly traded companies.
2024 © Pinnacle Digest. All rights reserved | Privacy Policy | Disclosure & Compensation | Terms of Use
Subscribe to our free newsletter for a weekly dose of the stories that move markets, and much more.
* By submitting your email you will receive our best content in your inbox weekly, which sometimes includes information about our sponsors. And you also agree to our Terms of Use and Privacy Policy.
